Infection by viruses of several different families is associated with neoplasia, and many instances are known in which products associated with these viruses are situated at the surface of both normal and malignant cells. It has proved difficult to link these virus-specific cell-surface molecules with either the cause or the progression of malignancy. For this reason we will consider in basic terms the possible mechanisms of virusinduced transformation, and the role that virus-associated cell-surface components may play in such events, and we will attempt to assess the relevance of known virus-specific changes within this framework.
Cells may become transformed by viruses whose life cycle is lytic as well as by nonlytic agents. In the former case the cell survives, either because it is non-permissive or semi-permissive for virus replication or because virus replication is defective. In the latter instance similar constraints may reduce the level of virus expression, but it is also possible for the transformed cell to yield fully infectious virus. Whatever the nature of virus-cell interaction, the transformed cell always carries virus genetic material, and viruses could thus transform by interfering with normal cell controls in several ways. Firstly, integrated viral DNA may disrupt regulated expression of the cell genome, a situation which does not require the expression of viral genes. Secondly, virus-coded products may mimic the effect, or even the detailed action, of cell growthpromoting stimuli. If the virus-specific molecules are located in or near the cell membrane they may mimic exogenous signals acting across the cell surface, but the viral products may also resemble endogenous signals for growth.
Such virus-coded or virus-specific growthpromoting stimuli could be (1) structural proteins of the virus or their precursors (in their native form or modified by mutation, recombination or aberrant processing in an unusual host), (2) non-structural proteins involved in virus replication (which may also undergo modification), or (3) non-structural proteins with no apparent function in the virus life cycle. The latter class of potential transforming proteins may be particularly important in the Retroviridae, whose mode of replication and high rate of genetic recombination make it likely that the virus can acquire, by recombination, a new genetic material from either the host or another virus. The new material may comprise a clearly defined cistron, distinct from viral replicative functions, or it may be part of a hybrid gene (derived by recombination within a viral cistron) which codes for a protein with some amino acids in common with a virus protein and others of foreign origin. If retroviruses recombine with one another, the viral replicative functions could also be altered, and some oncogenic viruses seem to arise by recombination between two non-oncogenic parents.
Only two virus genes have been shown, by reasonable genetic and biochemical criteria, to be involved in causing cell transformation; the early region (T-antigen complex) of papovaviruses and the src gene of sarcomainducing retroviruses. It is possible that the proteins encoded in these genes may have similar mechanisms for inducing cell transformation but, whereas the papovaviruscoded proteins are involved in virus replication, the src gene product seems unrelated to the virus life cycle and this gene is possibly of host-cell origin. The cellular location of these proteins and their detailed mode of action is not understood, and it is possible that they may show functional polymorphism. One component of the T-antigen complex is membrane associated (though not known to be on the cell surface) and the expression of both the papovavirus and the retrovirus genes in the cell is closely correlated with the presence of virus-specific tumour antigens on the cell surface. However, the relationship between these antigens and the viral transforming genes is not understood.
Another group of retroviruses, typified by the erythroblastosis and myelocytoma viruses of chickens and the Abelson leukaemia virus of mice, are replication-defective agents which all encode a protein which comprises a portion of the retrovirus gag gene and amino acid sequences of an unknown origin. For some of these viruses there is preliminary genetic evidence that these hybrid proteins may be a cause of cell transformation, but their location in the infected cell is as yet unknown.
In the case of other leukaemia-inducing retroviruses there is no clear evidence for the involvement of a virus gene in the maintenance of the transformed state, but there is ample documentation of the presence of virusassociated antigens on the leukaemic cell surface. Some of these antigens, such as the mouse Glx thymocyte antigen and Gross cellsurface antigen (GCSA) were known to be associated with leukaemia-virus-induced neoplasms, but were thought possibly to be of non-viral origin. However, it is now known that Glx antigenicity is carried on the murine leukaemic virus (MuLV) envelope glycoprotein, whilst GCSA represents glycosylated forms of the precursors to the internal proteins of MuLV encoded by the viral gag gene. With increasing awareness of endogenous virus-specific proteins, including the env and gag gene products, in normal as well as transformed cells, it is difficult to assign to these antigens a function in the causation of leukaemia It is possible that they are simply evidence of viral gene activity, which may be a prerequisite for leukaemogenesis but which may also be apparent in other stages in the life of the host. However, though we do not know whether the virus antigens on the surface of the leukaemic cells have a causal role in the neoplasm, they, like the surface tumour antigens associated with sarcoma viruses, are invariably present. If this novel antigenicity elicits an immune response from the host, the virus-associated surface proteins maybe an important factor in the progression of the disease.
CELL-SURFACE PROPERTIES, GROWTH AND MALIGNANCY OF HAEMOPOIETIC CELL LINES. K. NILS-
SON, The Wallenberg Laboratory, University of Uppsala, Sweden. During the last few years, improved tissueculture methodology has allowed the establishment of a number of cell lines in vitro from both normal and neoplastic human haemopoietic tissue and peripheral blood. Analyses of the phenotypic characteristics of haemopoietic lines have revealed that most of them are polyclonal and normal diploid in early passages, carry Epstein-Barr virus (EBV) and are therefore derived from presumably nonneoplastic precursor cells. Such cell lines, tentatively termed lymphoblastoid, can be established wi,ith ease from any anti-EBV7 seropositive individual. In contrast, truly neoplastic haemopoietic cell lines (leukaemia, lymphoma, myeloma) are still rare, and have been established only with great difficulty. The neoplastic lines are always monoclonal, aneuploid and, with exception for Burkitt's lymphoma lines, EBV-genome negative.
The lymphoblastoid lines (LCL) have a lymphoblastoid morphology, produce immunoglobulin (Ig) and express lymphocyte surface markers indicating a B-cell descent. The LCLs gradually evolve towards monoclonality and aneuploidy during continuous cultivation. This in vitro selection of an aneuploid clone usually occurs within one year of serial passage.
From the studies with the group of malignant haemopoietic lines a few general conclusions seem justified. Firstly, all the lines have individually distinct properties, suggesting that each human haemopoietic tumour, although sharing some basic morphological and functional features with other tumours belonging to the same histopathological entity, is unique. Secondly, haemopoietic tumours continue to express most of the features of the corresponding normal cells. Thirdly, the expression of the phenotypic properties is usually stable during at least 1-2 years of continuous cultivation in vitro. The leukaemic-cell lines are most frequently lymphoblastoid in morphology and usually have a T-cell-like phenotype. A few cell lines have surface characteristics indicating a non-T, non-B lymphocyte origin; even fewer lines have a suggestive B-cell origin. Recently, the first leukaemic cell line with myeloid characteristics has been established from a myeloid leukaemia. To date, 3 myeloma lines and 3 lymphocytic lymphoma lines have been reported. The myeloma lines express plasmacell surface characteristics while the lymphocytic lymphoma lines have a B-cell phenotype. The largest number of lymphoma lines has been established from diffuse histiocytic lymphoma. The phenotypic variability among these lines is suggestive of a marked heterogeneity with respect to cell type of origin in tumours classified histologically as "histiocytic". The majority produce Ig, and thus seem to be derived from the B-lymphocyte series. Some lines have a lymphocyte morphology but express no lymphocyte surface inarkers, and have therefore tentatively been classified as being derived from non-T, non-B lymphocytes. Three lines have morphological, lymphocyte surface marker and enzyme characteristics, indicating descent from a monocyte type of cell, and would thus represent truly histiocytic lymphomas.
The aimn of this overview is to describe some of our recent studies on cell-surface characteristics of malignant haemopoietic cell lines, with special reference to phenotypic properties assumed to be related to the neoplastic state of the cells. The main results wNill be briefly summarised in the following:
(1) Exposed surface glycoproteins (GP) have been studied in a panel of neoplastic (lymphoma, leukaemia, myeloma) and nonneoplastic (LCL) lines by the galactose oxidase-tritiated sodium borohydride labelling technique. The labelled GPs were separated by polyacrylamide slab-gel electrophoresis and visualized by autoradiography. Each type of malignant haemopoietic cell line was found to have a basic, easily distinguishable surface GP pattern. In addition, each line had one or a few unique GPs. The B and T lines had most GPs in common with normal B and T cells, respectively. The GPs most constantly associated with malignancy were found in B lymphomas as double bands with apparent mol. wts of 85-87 and 69-71. The nature of these GPs has not as yet been clarified. In leukaemia and myeloma lines, only unqiue GPs were found in addition to those shared with normnal cells. In the group of histiocytic lymphoma lines 4 types of GP patterns could be distinguished: (a) a basically B-lymphocyte-like pattern in 2 lines expressing B-cell surface markers; (b) a basically T-lymphocyte-like pattern in 1 line with non-T, non-B surface phenotype; (c) a basically monocyte-like pattern in 1 line with a monocyte-like phenotype: (d) a 'stem" cell-like pattern in 2 other lines with a histiocyte-like phenotype. The surface-labelling technique thus seems to be useful in discriminating the different types of "histiocytic" lymphomas.
(2) The fucose-labelled GPs of the haemopoietic lines were also characterized by gel filtration after degradation and release from the cell surface by proteolytic enzymes. The results demonstrate that the tumour lines, almost wAithout exception, contain an increased amount of fast-eluting glycopeptides than a larger normal cell. Such fast-eluting glycopeptides have previously been demonstrated in several animals and human tumours, but not in normal cells. Interestingly, the surface glycopeptides of the LCL type of lines also had this "malignant" elution profile.
(3) The binding of the lectin Helix pomatia agglutinin (HP) to the surface of the various types of cell lines has been studied. In T lines a selective binding to a GP with an apparent mol. wt of 150 ku was found, whilst in B lymphoma and myeloma lines this lectin bound to a 210 GP. The non-T, non-B leukaemias bound HP to a 150 ku GP. The group of histiocytic lymphoma lines was again heterogeneous. The (Table) . A detailed examination of the glycolipids of the thyroid GM2=Cer-Glc-Gal(NAN) GalNAc;
Abbreviations: Cer, ceramide; Glc, glucose; Gal, galactose; CalNAc, N-acetylgalactosamine; NAN, N-acetylneuraminic acid.
have resolved at least 28 sialic acid-containing glycolipids, one of which is markedly better at inhibiting TSH binding to thyroid membranes than the previous best inhibitor GDib.19 The molecule, wrhich has yet to be fully characterized, is a minor component of the total membrane glycolipid (0-015% of the total lipid-bound sialic acid; 104 molecules per cell). Other glycolipids, e.g. minor components of testicular membranes, may well act as the in vivo receptors for HCG and LH.
(b) The change in the fluorescence spectrum of the hormone induced by the glycolipid which is the best inhibitor of binding is distinct from that produced by a minimal inhibitor of binding. 6, 8, 9 (c) Also in support of the above data is the finding that the target tissues for TSH and HCG have unusually high levels of the more complex glycolipids for extraneural tissues. 6, 8, 9, 19, 20 Initially these results appear surprising, in that glycoprotein receptors for TSH and HCG have previously been isolated.21 '22 However, the primary determinant of the hormone-receptor interaction is probably a specific carbohydrate sequence, and it is not without precedent for the same carbohydrate sequence to appear in both glycolipid and glycoprotein.23'24 Membranes from a thyroid tumour which is unresponsive to TSH not only lack the glycoprotein receptor, but levels of the more complex glycolipids are also markedly reduced. 25 In the light of the possible dual nature of the glycoproteinhormone receptors, it is conceivable that a glycoprotein receptor for cholera toxin remains to be discovered.
However, some doubt about the role of glycolipids as the primary receptor for the glycoprotein hormones still remains, stemming from the observation that, whilst injection of HCG into rats leads to a reduction in HCG binding by testicular membranes, the glycolipid profile of the membranes is unaltered.20 In addition, glycolipids extracted from the testes of treated rats were as effective as those from control animals in inhibiting 1251-HCG binding by isolated testicular membranes. Similar questions are posed by the finding that whilst thyroid cells from patients with Grave's disease bind normal amounts of TSH, the glycolipid profile of the cells is altered.26 It would be interesting to re-examine the glycolipid profile of these cells in the light of the more recent data showing that the putative glycolipid receptor for TSH is a very minor component of the thyroid cell membrane. 19 Given that glycolipids are candidate membrane receptors for certain hormones, their loss from the tumour-cell surface may well place the cells outside the sphere of influence of those mechanisms which normally regulate the expression of certain of the differentiated cellular functions. An additional role for glycolipids in cell-cell-interaction has been proposed.27 Recent evidence suggests that glycolipids are important cell-surface determinants in retinotectal adhesion28 and nervemuscle interaction.29 Clearly, were these observations confirmed and extended, loss of cell-surface glycolipids might be an important factor in the breakdown in cellular interaction characteristic of malignant cells.2 53. 28 lag phase, two signals, 1 and 2 are postulated. Signal 1 initiates the lag phase and signal 2 determines the value of k. The times during the lag phase when hormones must be present to effect changes in the value of k suggest that the pathway triggered by signal 1 is organised in a linear sequence of steps during this period, and that the change in the putative rate-limiting step which is responsible for first-order kinetics is situated near the end of the lag phase.9"13"14 Similar conclusions concerning the position of this "rate-limiting step" have been obtained from experiments with inhibitors of protein synthesis. 15 Turning to the detailed study of the interaction of growth factors with their target cells, two basic mechanisms have been suggested for EGF. (1) The growth factor binds to specific receptors in the plasma membrane16 and thereby triggers specific messengers' (cyclic nucleotides, ions, nutrients) which continue the stimulus inside the cell. (2) The growth factor is internalized and goes directly to intracellular sites17 concerned with the growth stimulus. These possible effects may not be mutually exclusive. Three lines of evidence suggest that the first mechanism cannot be the complete story.
(1) 3T3 cells partially starved for certain nutrients cannot increase their proliferation rates with FGF.18 (2) The magnitude of early changes1"19 in cyclic nucleotide and ion concentrations and transport of nutrients triggered by PGF2a or FGF do not necessarily show correlations with the final value of k.2,14 (3) EGF stimulates many of the early changes in a 3T3 cell variant, but fails to increase the value of k, whereas PGF2cx behaves normally, suggesting an EGF-specific interactior with the cell beyond plasma-membrane binding (unpublished results). On the other hand there is no evidence as yet to suggest that internalization and accumulation of EGF by the cell is involved in the delivery of the mitogenic signal. 20 Even more difficult to understand is the constancy of the lag period, independent of PGF or PGF2oX concentrations, before increased values of k are observed. We have suggested2 that the constancy of this period is due to a requirement for interaction of the pathways generated by signal 1 and signal 2 before an intracellular component becomes ..competent" to cause increased values of k at the end of the lag. The nature of this hypo-thetical component is unknown, but since only the later events which result from changes in the amount of proteins inside the cell show consistent correlations with the value of k to date,2 and since there is a strict requirement for protein synthesis for changes in k at the end of the lag phase,15 it is not unreasonable to suppose either that this component may be a protein which has to be modified or a modification to the cell has to take place before this component becomes "competent" to cause an increase in k. One obvious candidate is a cellular equivalent to the small DNA tumour-virus nuclear T antigen which can stimulate host-cell DNA synthesis when injected directly into quiescent cells.21 Interestingly, the apparent relative rate of accumulation of a nuclear nonhistone protein seen near the end of the lag phase after addition of PGF2a to quiescent cells is correlated with the final value of k.22 Experiments are in progress to isolate this and other proteins, and to test for their effect on k by direct microinjection into quiescent cells (L. J. de A., unpublished).
Chemical or viral transformation of fibroblasts in tissue culture produces cell variants with different properties from the original cells, including increased ability to form tumours in animals (review ref. 23) . One different property is their response to growth factors. Thus FGF can stimulate cell replication in untransformed 3T3 cells, but not in polyoma or SV 40-transformed 3T3 cells6 or in 3T3 cell transformation mutants at the temperature at which the cells are transformed. 24 It has been suggested that a possible mechanism for transformation in vitro and forination of a neoplastic cell in vivo is due to an increased ability of cells to produce their own growth factors, so ensuring a degree of cellular autonomy from external control by growth factors present in serum.25 '26 In particular, the fact that inurine sarcoma virus-transformed fibroblasts fail to bind EGF at the cell's surface but produce EGF-like polypeptides which compete for binding with EGF to cultured cells, has suggested that the transforming sarc gene product may be a growth factor which binds to the plasma membrane, causing the altered properties and failure of these cells to bind EGF.27 This hypothesis fails to explain some of the other changes which accompany transformation in fibroblastic cells (e.g. cell-surface glycoprotein changes, increased protease activity, reduced celladhesive properties) which can be observed independently of changes in proliferation rates in temperature-sensitive mutant BALB/c 3T3 cells.28'29 A more likely explanation is that the sarc gene product has more general effects on the plasma membrane, one of which may be to alter its binding of certain growth factors. However, it may not be unreasonable to conceive that one of the transforming viral gene products associated with increasing host-cell proliferation rates, the nuclear T antigen of the small DNA tumour viruses, may be acting like the hypothetical host-cell "component" for maintaining increased cellular proliferation rates. In this way the transformed cell may perpetuate the stimulus for increased values of k that the growth factor produces in untransformed cells. preparation). 23 Two mechanisms of cell-cell communication have evolved to allow the coordination of cellular'functions in multicellular organisms. One mechanism depends on extracellular signal molecules (e.g. hormones, synaptic transmitters); the other depends on the formation of permeable intercellular junctions. Both mechanisms appear to be ubiquitous throughout the plant and animal kingdoms.
The permeability of junctions formed between animal cells is well established. Small ions and molecules are freely exchanged between the cytoplasms of all the cells in a coupled population, but macromolecules remain within the cells where they were synthesized (or their daughter cells which arise through division).1.2 The exchange appears to take place by simple diffusion through specialized membrane structures (gap junctions) which bypass the normal permeability restrictions of the plasma membrane.3A4
In excitable tissues, permeable junctions can provide intercellular, low-resistance pathways for the propagation of electrical impulses. In non-excitable tissues, where the junctions are generally more numerous, they allow the equilibration of metabolite pools between cells. This can result in a tissue "phenotype" which is characteristic of a particular mixture of cells and which is different from the phenotypes of the'separated cells.
In model systems in tissue culture, it has been shown that metabolic interactions through permeable junctions can result in the intercellular control of enzyme activities and cell proliferation. 5 Gap Evidence obtained in several laboratories over the last few years has shown that metastasis is not a random process in which each cell in a malignant primary tumour is capable of producing a metastatic lesion, but is instead caused by specialized subpopulations of cells within the primary tumour which are endowed with the properties needed to successfully complete all stages of the metastatic process.1-3 Recognition that not all the cells in a malignant primary tumour possess the properties needed to metastasize, has major implications for the choice and design of experimental systems for the study of metastasis. Studies on unselected. heterogeneous tumour-cell populations isolated from the primary lesion may offer little insight into the properties of metastatic cells, since the proportion of non-metastatic cells may be sufficiently high to prevent detection of properties which are unique to the metastatic subpopulation(s). Analysis of the malignant phenotype thus requires isolation and characterization of subpopulation(s) of malignant cells endowed with the full complement of properties needed for expression of metastatic behaviour.
The isolation of tumour-cell populations with invasive and metastatic properties has required the development of new methods whereby these cells can be reliably separated from cells lacking these behavioural traits. Recently, techniques have been devised which permit quantitative measurement of the ability of tumour cells to invade segments of chick chorioallantoic membrane, murine bladder wall and mammalian blood vessels cultured in vitro, and which also enable the invasive cell subpopulations to be reiso- Recent studies on the adhesion of cells to collagen in vitro7 and to the surface of blood vessels maintained in vitro in perfusionculture, have revealed major differences in the behaviour of normal and tumour cells which may be relevant to the arrest of circulating tumour cells in the vascular bed and their subsequent extravasation to form micrometastases in the surrounding tissues. Normal cells adhere equally well to collagens of Types I, II, III or IV, but their adhesion is always serum dependent.7 In contrast, metastatic tumour cells display a significantly higher affinity for adhesion to Type IV collagen and adhesion is serum independent.7 Type IV collagen is found in the basement membrane of blood vessels, and these findings raise the intriguing possibility that the greater affinity of malignant cells for this substrate may aid their metastatic behaviour in vivo by facilitating cell arrest and extravasation. Other studies8 on the adhesion of normal and tumour cells to blood vessels in vitro also support this view. Normal and malignant cells do not differ significantly in their ability to adhere to intact endothelium, but metastatic cells adhere more rapidly and in greater numbers to blood vessels denuded of endothelium. In the latter situation cell adhesion thus occurs directly to the basement membrane.8 Perhaps of more importance is that the same differences in adhesion between normal and malignant cells have also been detected after minimal damage to the endothelium, in which the endothelial cells remain attached to the basement membrane but retract to create large intercellular spaces where the basement membrane is exposed. Since structural alterations of this kind can be induced in vivo merely by reduced London.
An immunofluorescent study of the plasmamembrane antigens of an in vitro human pancreatic-cancer line was carried out using antisera to gastric and colonic cancer, normal omentum, 32-microglobulin and gluteraldehyde-fixed whole cells. Persistent staining after suitable adsorption of the whole-cell antiserum suggested the presence of tumourspecific determinants. The expression of /2-microglobulin on the cell surface was used to develop an immuno-affinity procedure for the further purification of plasma-membrane components by specific adsorption of the membranes to immobilized anti-$2 antibody; desorption was achieved by detergent solubilization of retained membranes followed by PAGE characterization. and tumour load, as does the observed lowering of /32m in some patients after chemotherapy. In remission, /2m levels tended to be normal, though a group of HNL patients was observed with persistantly high fl2m, possibly due to residual disease. Most patients with chronic lymphocytic leukaemia had persistently raised f32m levels (76%) and there was no correlation between /32m levels and lymphocyte count. Elevated f32m was also present in 82% of patients with Burkitt's lymphoma. In bladder cancer patients with normal renal function as determined by serum creatinine levels, the frequency of raised serum ,B2m increased with tumour stage (15% TI, 57% T4) though a large number of patients had impaired renal function, making serum fl2m measurement of little value. Few elevated g2m levels were found in prostatic cancer despite large tumour loads (30% raised in a no treatment M+ group).
Whether this indicated low /32m production by tumour cells or little host reaction to this type of tumour is uncertain. /2m levels in choriocarcinoma were also seldom elevated, possibly a result of intensive chemotherapy and immunosuppression or a deficit of HL-A.
The support of physicians and surgeons in Yorkshire and elsewhere is acknowledged. Cell-surface glycoproteins play important roles in control of differentiation, cell interactions and probably the proliferative and metastatic abnormalities of tumour cells: regulation of synthesis and expression of specific glycoprotein ligands is clearly of importance in these processes. We have studied the effect of the cellular environment on membrane glycoproteins and GAGs of human skin fibroblasts by culturing cells on plastic or collagen-gel substrates. Confluent monolayers, incubated for 48 h with 3H-glucosamine and Na235SO4, were extracted with trypsin (0.5 mg/ml) when cultured on plastic, and by trypsin followed by collagenase (2 mg/ml) for cells on collagen gels which were not detached by trypsin. In cell-free extracts, heparin sulphate (HS) was the main sulphated GAG from cells on plastic with dermatan sulphate (DS) the minor component: on collagen gels, however, DS was more abundant than HS. Collagen-gel cultured cells were also enriched in cell-associated hyaluronic acid and a distinct acidic glycopeptide. We conclude that the cellular environment in vitro influences the synthesis and disposition of cell-surface glycoproteins and GAGs. GmbH.
CELL-SURFACE GLYCOPROTEINS AND GLYCOSAMINOGLYCANS (GA
Changes in cell surfaces are believed to be involved in the regulation of cell growth. The idea that the surfaces of neoplastic cells differ from those of their normal counterparts has received support from various lines of research. To substantiate this view by a physical method, secondary-ion mass spectrometry (SIMS) was applied on N-methyl-Nnitrosourea-induced pleomorphic glioma and glial cell surfaces. SIMS allows researchers to monitor small molecules, of up to 10, probably more, atoms, which can be derived from various depths in the plasma membrane. All spectra of the positive ions showed a pattern of grouped peaks between 50 and 150 atomic mass units (u). A comparison of the relative distribution of the grouped peaks revealed that the decrease of the impulse heights towards higher u is steeper in the spectrum obtained from glia than from glioma. In addition, glial and glioma cells showed a characteristic positive ion peak at 148 u. The impulse height of the 148u peak was significantly lower within the glial cells, than the averaged impulse heights of the above grouped spectral lines. Evaluation of the 148 u in deeper layers of the membrane exhibited a small, continuous decrease of the impulse height within increasing membrane depths. The same experiment with glioma cells revealed a dramatic decrease of the 148 u in deeper membrane layers. These results suggest that (i) glioma cells express at the very topic of the cell surface a higher quantity of molecule(s) from which a 148 u can be fragmented than do glial cells and (ii) there is a different distribution of the original molecules. Further investigations should be undertaken to sort out whether SIMS might become a powerful tool for membrane-molecule fragmentation and, thus, to contribute to understanding neoplasia in terms of cell-surface transformation. Although infection of cats with feline leukaemia virus (FeLV) is relatively common, leukaemia is a rare consequence. Recovery from FeLV infection is due to an immune response to viral antigens in which virus-neutralizing antibodies are produced. In addition, cats may make antibodies to a virus-induced non-virion antigen (FOCMA) which appear to protect them from the leukaemogenic effects of the virus. Antibodies to FOCMA were first recognised in cats with regressing feline sarcoma virus-induced tumours. Recently, FOCMA was defined as a tumour-specific cell-surface antigen which is induced in cats by FeLV infection and may be coded for by the FeSV genome. It is also found on leukaemic cells in cats with no evidence of FeLV infection (virus-negative leukaemias). We are attempting to isolate FOCMA from tumour-cell lines using immunoprecipitation and SDS polyacrylamidegel electrophoresis. We thus hope to confirm the immunological evidence for this antigen and to assess its role in cell transformation and in the immunity of cats to FeLV and its leukaemogenic properties. Synchronized feline lymphoblastoid cells (FL 74) chronically infected with feline leukaemia virus (FeLV) have been examined, during the different phases of the growth cycle, by the combined means of cytoplasmic and viable-cell indirect membrane-immunofluorescence techniques (IFA), electron and immunoelectron microscopy (EM, IEM) and scanning electron microscopy (SEM).
CELL-CYCLE-RELATED CHANGES
Using IFA and EM techniques, it has been found that virus production and viral protein expression are cell-cycle dependent and occur near mitosis.
In order to establish a more precise timing of the above events, immunoferritin labelling and SEM of synchronized cells were performed.
Several distinct changes were found in surface morphology, which correlated with the subdivisions of the cell-cycle, and analysis of the surface morphology, ultrastructure, the number of budding C-type particles, the distribution and intensity of ferritin-labelled antigenic sites allowed the identification of individual cells in the cell cycle. Although the distribution of the antigen is widespread, it is highly selective, apparently localized to membranes associated with a secretory function and adenocarcinomas. We lhave shown that EMA is different from carcinoembryonic antigen (CEA), normal cross-reacting antigen (NCA), fl-oncofoetal antigen (BOFA), pregnancy-specific glycoprotein (/31SP1) and the blood-group substances A, B, Lewis a and Lewis b, by comparing their distribution in various tumours and some absorption studies. Like CEA in poorly differentiated tumours, the antigen is frequently cytoplasmic in distribution.
Since the antigen is carried by a variety of adenocarcinomas its demonstration in minute foci of malignant cells in the marrow and lymph nodes is but one example of a possible role in the diagnosis and differential diagnosis of malignant disease. vestigated by whole-mount TEM and SEM of the same cell, and also underside replicas produced by freeze fracture. Ruthenium-red staining of the whole-mount preparations has also illustrated the production and involvement of cell-coat material in these regions. The regions of attachment are characterized by a reticulate appearance of the peripheral cytoplasm, in roughly circular regions of 5-10 ,um in diameter. These areas appear in the lamellar regions of spreading epithelial cells, or leading edges of fibroblasts, and appear concomitant with a loss of membrane ruffling. Initially these regions show no insertion of microfilaments, but an association may be developed subsequently. As well as becoming the initial sites of membrane alteration during settling and locomotion, these areas are also the most resistant to the effects of trypsin and EGTA and may consequently correlate with the substratum-attached material (SAM) which remains after cell detachment. The majority of previous reports dealing with cell attachment to collagen have used collagen films extracted with urea as a substratum; these studies have demonstrated that cell attachment to such films is dependent on a high-mol.-wt glycoprotein (variously known as LETS, fibronectin, CSP, CAP etc.) found both in serum and on the surface of normal fibroblasts. In the preseilt communication, we wish to report that only cell attachment to denatured collagen films is dependent on this glycoprotein, and that cell attachment to native collagen fibres is mediated by a different (serum-independent) mechanism. This conclusion is supported by observations comparing the kinetics and extent of cell attachment: (a) A model has been developed for studying the capability of cells from primary mammary tumours to establish colonies in distant organs. The aim was to avoid the use of repeatedly transplanted tumours or serially propagated tumour cell lines. The model involves the intravascular inoculation of disaggregated tumour cells into autochthonous and syngeneic recipients. The results show that the colonization potential of cells from a given tumour is consistent between the animals of an inoculated batch. Also, the findings are similar in the autochthonous host and the syngeneic recipients. Tumours vary in their metastatic colonization potential and can be classified into high and low groups. These findings indicate that: (i) A significant proportion of mammary tumours (40%) are capable of establishing colonies in distant organs even though the incidence of metastatic spread of these tumours in the undisturbed animal is almost zero.
LYMPHOCYTE-STIMULATION BY

FACTORS INFLUENCING CELL AT
(ii) The colonisation potential of the tumours is an intrinsic property of the tumour cells rather than of the host.
The model will now be used to study cellular properties which favour colonization of distant organs. The exposure of cells to trypsin revealed the series of events leading to the assumption of a spherical morphology prior to cell detachment from the substratum. It was seen that the method of cell rounding was cell-shape dependent.
A COMPARISON OF THE SURFACES OF TUMOUR CELLS ISOLATED FROM
Fibroblasts possess points of adhesion at the tips of their polar regions. Continued trypsin-induced cytoplasmic contraction applied stress to the adhesion points until attachment was released at each pole in turn. This produced recoil of the polar regions under elastic tension to produce spherical cells w%Nith a blebbed surface morphology.
Cells of epithelial outline assumed a spherical shape with a microvillous cell surface bv slow retraction of the cvtoplasm around the entire cell periphery. An epithelial outline wvas maintained throughout the rounding-up process. The alteration of cell shape as fibroblasts progressed through the cell cycle by transformation or induced bv various experimental metlhods shoNwed the same results. The visual detection and localization of specific molecules on1 the cell surface by SEM is possible using probes such as colloidal gold, methacrylate latex spheres and defined silica spheres. This approach is being applied to studies designed to explore and correlate the expression and topographical distribution of cell-surface components with cell-surface features in normal and neop)lastic tissues.
Work is currently in progress to evaluate the characteristics, preparation and further applicability of these probes and their ligandmarker conjugates. Isoproterenol (IPR), a synthetic catecholamine, induces cell proliferation in acinar cells of mouse parotid glands when injected i.p. The role of the plasma membrane in the induction of DNA synthesis is being studied. Plasma membranes from this tissue were isolated by differential and discontinuous sucrose-gradient centrifugation at different stages of the cell cycle, and the activity of different enzymes known to be "markers" for these plasma membranes were studied in order to have an additional element of structural and functional analysis of this compartment of the cell cycle. The results show that between 0 and 28 h (injection of IPR and onset of DNA synthesis respectively) the specific activities of these plasmamembrane markers change continuously, which could reflect an active role of the cell surface during the cell cycle. Moreover, the description of changes in specific molecules with better known physiological functions could help to understand the participation of the cell surface between the stimulation and onset of DNA synthesis. L'Characterization of the cell-surface components of tumour cells is important for an understanding of the role these materials may have in malignancy. We have used iodination with 125J in the presence of lactoperoxidase to label the cell-surface proteins and glycoproteins of melanoma cells. The labelled components were separated by SDS electrophoresis on 5-22.5% polyacrylamide gradient gels and detected by autoradiography. Fractionation of extracts of the labelled cells by affinity chromatography on immobilized lectins indicated that both proteins and glycoproteins were labelled. Identification of some of the labelled bands was achieved by addition of immune sera to extracts of the iodinated cells followed by examination of the immune complexes retained on Staphylococcus aureus. In this way proteins originating from foetal calf serum used in the culture medium and glycoproteins cross-reacting immunologically with those of erythrocytes, lymphocytes and fibroblasts were detected on the melanoma cell surface. We have previously documented the presence of a cell-surface antigen found in acute lymphoblastic leukaemia, chronic myeloid leukaemia in blast crisis and some lymphomas (Greaves, et al. (1975) Antigens, 1, 153 ). An ascitic tumour (SEWA) induced by polyoma virus in A.SW mice was analysed in vivo as well as in vitro with regard to the electrophoretic mobility (EPM) which may be considered as a reliable criterion of surface charge. After the i.p. inoculation of 105 cells, the EPM decreased up to 14th day ,tm/ sec/Vcm). Then the mobility gradually increased with the age of the tumour. The EPM was 1-58 ,um/sec/Vcm for 28-day-old tumours. Chemical modification of cell surface with maleic anhydride and neuraminidase showed important variations of ionized chemical groups in 14-and 28-day-old tumours. Amino groups showed a drastic decrease during the late phase of tumour growth. In contrast, the number of o-carboxyl groups of N-acetyl neuraminic acid markedly increased. On the other hand, incubation with antisera of mice immunized against SEWA are without effect on electrophoretic mobilities. When SEWA was maintained in vitro, the EPM reached a peak 24 h after renewal of the medium. This increase was not seen when cells were treated with cytosine arabinoside. Though EPM variation in this case may be interpreted on the basis of cell-proliferation kinetics, the interpretation of in vivo results is more complex. These results led us to suggest that changes observed in vivo might be the consequence of different independent parameters. Besides intrinsic factors such as cell kinetics, extrinsic factors are able to modify pericellular environment. We have considered the possibility of cell coating by immunoglobulins present in ascitic fluid. proportions of labelled cells from the computer analysis with those from conventional integration above and below an arbitrary level set "by eye" in each instrument, permit the following conclusions. (1) Due to the high coefficient of variation and low laser power of this model of the CFG, an accurate quantitation of data can only be obtained by computer analysis. (2) Both the conventional integration above and below an arbitrary response level set "by eye" and the computer analysis gave similar results with the FACS, but the data indicate that the discriminating level should be checked by computer if the conventional method is chosen. (3) Whichever instrument, or method of data evaluation is chosen, it is essential to carry out experiments with serial dilutions of the fluorescent antiserum to determine the optimum experimental conditions. (4) It is necessary to determine the fraction of non-specifically labelled cells in the sample, "even with monoclonal reagents. To examine these possibilities further, in the present study the antigenicity of in vivo lines established from opposite poles of primary sarcomas have been compared, and with one primary tumour-bearing animal the antigenicity of lines established from peritoneal, renal and pulmonary metastases have also been examined. Sublines from 4 primary tumours cross-reacted, so that immunization against one line conferred protection against the other. With a 5th tumour, neither subline was antigenic, although they had similar growth characteristics. In contrast, sublines from 3 furthler sarcomas were antigenically distinct, so that immunization against the subline from one pole failed to protect against the other. Furthermore, with one primary sarcoma, while the line from a peritoneal metastasis tross-reacted -vith lines from the primary tumour, neither of these crossreacted with lines from pulmonary and renal metastases, although these latter were crossreactive with each other.
COMPUTER ANALYSIS OF IMMUNO
These studies demonstrate that antigenic heterogeneity can exist within established priinary tumours, and that metastases may be antigenicallv distinct from the primary tumouir.
SURFACE ANTIGENS ON NORMAL AND TRANSFORMED LYMPHOID CELLS. C. M. STEEL, V. VAN A method of detecting circulating immune complexes, which combines PEG precipitation, adsorption to S. aureus protein A and PAGE analysis of the fractionated material, was used to screen sera of patients with various types of malignant disease. To date, differences from the control pattern of protein bands produced by PAGE of fractionated normal sera, have been most readily obtainable with the cases of Hodgkin's and some other lymphomatous disorders. Judged by electrophoretic mobility and serological reactivity, an excess of apparently free immunoglobulin light-chain (LC) is present in a number of these patients' sera during active disease. Evidence will be presented showing the tendency for serum LC to return to normal levels during clinical improvement due to chemotherapy. This interesting relationship warrants further investigations of the potential value of serum LC monitoring in the clinical management of certain human lymphomas. Ultrastructural studies have shown that this lymphocyte attachment ranges from point contacts by lymphocyte mierovilli to close apposition of large areas of the two cell membranes, some stretches being regularly spaced at 10-15 nm apart. There were no membrane fusions, junctions, specializations of the underlying cytoplasm or lymphocyte invaginations, and no evidence of ultrastructural damage to the RS cells. RS cell/ lymphocyte clusters may persist for 5 weeks in culture without loss of viability. Pharmacological studies have shown that this interaction is dependent on intact surface proteins (on both the lymphocytes and RS cells) and on divalent cations. It is independent of temperature, cell metabolism, intact microtubules and microfilaments and protein synthesis.
These features indicate that the attached T cells are not cytotoxic, and that this is a non-specific interaction unrelated to antigendependent immune adherence. Chemotactic factors enhance the expression of complement receptors on human leucocytes, i.e. they produce an increase in the percentage of leucocytes which form rosettes with complement-coated red cells ("complement receptor enhancement"). The phenomenon was originally described with eosinophils and eosinophil chemoattractants (Anwar & Kay (1977) Nature, 269, 522). Recently we have shown that complement receptors on neutrophils and monocytes were similarly enhanced. For instance, casein, a monocyte chemoattractant, enhanced monocyte C3 receptors in a dose-and timedependent fashion. We have also studied the capacity of dialysates from human lungcancer homogenates to inhibit enhancement of monocyte complement receptors ("enhancement-inhibition"). All the tumourderived material so far examined produced "enhancement-inhibition" (4 undifferentiated, 4 squamous and 4 adenocarcinomas). The effects of the tumour-derived material were significantly greater than that of normal lung distant from the tumour. Preliminary studies suggest that the activity present in lung-cancer homogenates giving "enhancement-inhibition" is associated with a mol. wt A programmable calculator with digitiser input can be used to measure the exposed surface area of cultured cells, neglecting the small folds and projections which are not resolved by the light microscope. We have found that this area is related to serum concentration. Hamster fibroblasts show a 4-fold reduction in exposed area as the serum concentration is increased from 5% to 66%. At the higher concentration the mean exposed area of these cells is equal to the surface area of spherical cells, such as are seen in suspension culture. We have also found that the transition probability (a measure of growth rate) is more than 10 times greater in attached cells than in suspended cells, in 5% serum. At a serum concentration of 66%, the probabilities in attached and suspended cells become equal. It seems possible, therefore, that the only important difference between attached and suspended cells is the area of the surface exposed to the medium. Suspension inhibition, like density-dependent inhibition, may be a simple consequence of the rate of diffusion of serum growth factors. BALB/c and Swiss 3T3 cells showr an 8-fold difference in sensitivity to inhibition of DNA replication and thymidine-labelling index by cytochalasin B. They show a similar relative sensitivity to reduction in exposed surface area by the drug. These results, and observations of interacting effects of cell density, cytochalasin B and colchicine on BALB/c 3T3 cells, may be explained in terms of the exposed-surface-area model of growth control.
CLASS-SPECIFIC ANTIBODY RES-PONSES TO SURFACE ANTIGENS OF HERPES-INFECTED CELLS
CYTOSKELETAL ELEMENTS AND
The involvement of microfilaments and microtubules in growith-control processes may be to alternatively restrict or optimize the exposed surface area of a cell and thus its interaction with macromolecular growth factors. small, and w-as accompanied by a nmore compact colony morphology, implying greater cell-cell and cell-substrate adherence. When colonies reached 1000-2000 cells proliferation was reduced in treated colonies, producing greater uiiiformity in colony size than in controls, where a minority of colonies grow to a larger size than treated colonies. Glucocorticoids reduced the lower terminal cell density of high-density multilayers and reduced incorporation of 3H-thymidine and lowered the labelling index. It appears that one effect of glueocorticoids on glioma is to promote cell adhesion and proliferation at initiation of clonal growth, but subsequently the effect on a high-density population is cytostatic.
INTERCELLULAR JUNCTIONS IN
Since glucocorticoids may stimulate cell adhesion by inducing synthesis of cell-surface glycoprotein, this may have led to better cell attachment and spreading, resulting in increased proliferation at low cell densities, A variety of adherent sarcoma, carcinoma and normal cells are surrounded by thick coats in vitro (around 9 ,um thick) that can prevent spleen cells, as well as a variety of other cells and particles, from coming near to the cell membranes. This was obvious from the presence of large transluscent halos around the cells, which the indicator particles could not enter. Seven lymphoblastoid cell lines failed to show halos.
The presence of the thick coats of fibrosarcoma cells appeared to protect these cells from lymphocyte-mediated cytolysis. Hyaluronidase treatment, which destroyed the halo and allowed lymphocytes to approach the tumour-cell membrane, enhanced the cytotoxic action of immune but not of normal spleen cells. However, little is known of the cellular events which occur in primary lesions. As an attempt to monitor the histogenesis of such lesions, we have investigated the electrokinetic (surface charge) and antigenic properties of individual cells from mesenteric lymph nodes (MLN) during the development of spontaneous RCS in 10-14-month-old SJL/J mice. In the early stages of MLN enlargement a bimodal electrophoretic distribution was regularly observed, with a low mobility (LM) peak corresponding to SIg+, Ia+, Thy 1-2-B cells (35%/) and a high mobility (HM) peak corresponding to Thy 1-2+, SIg-, la-T cells (65%). As the cellularity of MLN increased, there was first an increase, then a decrease in the frequency of LM cells. In the ultimate stages of MLN hypertrophy, the bimodal pattern was replaced by a single electrophoretic peak in the HM region. Size analysis revealed the existence of at least 2 physical types of cells with lymphoid morphology. 
